Table 2.

Preliminary analysis of CB91, LV58, LV62, and LV50 ^a.

Compound	Trypan Blue Positive Cells (%)	Viability (%)	subG1 Phase (%)
24 h
CB91	2.10 ± 0.13	83.35 ± 7.34	2.35 ± 0.16
LV62	7.60 ± 0.55	86.75 ± 7.37	3.45 ± 0.27
LV58	2.85 ± 0.20	87.80 ± 7.26	2.41 ± 0.18
LV50	18.13 ± 1.26	77.78 ± 6.22	7.85 ± 0.60
48 h
CB91	2.15 ± 0.16	78.80 ± 6.30	2.82 ± 0.17
LV62	10.5 ± 0.82	82.33 ± 6.25	8.88 ± 0.61
LV58	3.50 ± 0.22	85.50 ± 6.85	4.50 ± 0.26
LV50	23.93 ± 1.91	70.90 ± 5.31	18.7 ± 1.40
72 h
CB91	2.30 ± 0.18	75.45 ± 4.35	3.93 ± 0.18
LV62	14.80 ± 0.88	70.25 ± 4.21	10.60 ± 0.53
LV58	3.8 ± 0.25	81.25 ± 4.46	5.19 ± 0.33
LV50	30.00 ± 2.05	59.32 ± 3.85	24.70 ± 1.95

^a Data represent mean ± SD of different experiments.